DECREASED EXPRESSION OF COMPLEMENT RECEPTOR TYPE-2 (CR-2) ON NEOPLASTIC B-CELLS OF CHRONIC LYMPHOCYTIC-LEUKEMIA

被引：0
|
作者：
TOOZE, JA
BEVAN, DH
机构：
来源：
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1991年 / 83卷 / 03期
关键词：
CR2(CD21); B-CLL; FLOW CYTOMETRY;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Neoplastic cells from 49 patients with B cell chronic lymphocytic leukaemia (B-CLL) were studied and compared with normal peripheral and tonsillar B cells using CD21 monoclonal antibodies. Membrane expression of CR2 was quantified by calibrated flow cytometry and by binding analysis with radiolabelled antibody. Both assays indicate that B-CLL cells express only 30% of the CR2 found on normal B cells. These findings are further evidence of the aberrant phenotype of B-CLL cells.
引用
收藏
页码：423 / 429
页数：7
相关论文
共 50 条
  • [41] REGULATION OF COMPLEMENT RECEPTOR-2 (CR-2) EXPRESSION IN HUMAN B-LYMPHOBLASTOID CELL (BLC) LINES
    TOLNAY, M
    LAMBRIS, JD
    TSOKOS, GC
    FASEB JOURNAL, 1995, 9 (03): : A212 - A212
  • [42] Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4
    Macsik-Valent, Bernadett
    Uzonyi, Barbara
    Lukacsi, Szilvia
    Kiss, Richard
    Torok, Katalin
    Kremlitzka, Mariann
    Bajtay, Zsuzsa
    Demeter, Judit
    Bodor, Csaba
    Erdei, Anna
    MOLECULAR IMMUNOLOGY, 2017, 89 : 123 - 123
  • [43] Functional studies of chronic lymphocytic leukemia B cells expressing β2-integrin type complement receptors CR3 and CR4
    Uzonyi, Barbara
    Macsik-Valent, Bernadett
    Lukacsi, Szilvia
    Kiss, Richard
    Torok, Katalin
    Kremlitzka, Mariann
    Bajtay, Zsuzsa
    Demeter, Judit
    Bodor, Csaba
    Erdei, Anna
    IMMUNOLOGY LETTERS, 2017, 189 : 73 - 81
  • [44] INTERFERON-ALPHA-2B IN THE TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA OF THE B-CELL TYPE
    SCHLAG, R
    FLIEGER, D
    ZIEGLERHEITBROCK, HWL
    HILL, W
    EMMERICH, B
    THIEL, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 115 (28-29) : 1088 - 1095
  • [45] THE MALIGNANT B-CELLS FROM B-CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS RELEASE TAC-SOLUBLE INTERLEUKIN-2 RECEPTORS
    KAY, NE
    BURTON, J
    WAGNER, D
    NELSON, DL
    BLOOD, 1988, 72 (02) : 447 - 450
  • [46] IMPAIRED EXPRESSION OF CELL-SURFACE RECEPTORS FOR B-CELL GROWTH-FACTOR BY CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS
    PERRI, RT
    BLOOD, 1986, 67 (04) : 943 - 948
  • [47] IMPAIRED EXPRESSION OF CELL-SURFACE RECEPTORS FOR B-CELL GROWTH-FACTOR BY CHRONIC LYMPHOCYTIC-LEUKEMIA B-CELLS
    PERRI, RT
    CLINICAL RESEARCH, 1985, 33 (04): : A837 - A837
  • [48] POLYCLONAL HYPERGAMMAGLOBULINEMIA IN A CASE OF B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - THE RESULT OF IL-2 PRODUCTION BY THE PROLIFERATING MONOCLONAL B-CELLS
    MOUZAKI, A
    MATTHES, T
    MIESCHER, PA
    BERIS, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 345 - 349
  • [49] RETINOBLASTOMA PROTEIN EXPRESSION IS ALTERED BY 2 MECHANISMS IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    KORNBLAU, SM
    CHEN, N
    DELGIGLIO, A
    OBRIEN, S
    DEISSEROTH, AB
    BLOOD, 1993, 82 (10) : A44 - A44
  • [50] INCREASE IN SURFACE IMMUNOGLOBULIN-BEARING CELLS AND A RELATIVE DECREASE IN COMPLEMENT RECEPTOR CELLS IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    KATZ, J
    LEA, R
    SOUTH AFRICAN MEDICAL JOURNAL, 1979, 55 (04): : 132 - 137
12345